Biofil Chemicals Share Price Today | Stock Price & Biofil Chemicals Share Screener
As of October 5, 2026, the live Biofil Chemicals share price (NSE: BIOFILCHEM) is ₹29.64 on NSE and ₹29.57 on BSE, up 1.13% from the previous close, with shares trading between ₹29.17 and ₹30.94 in today's trading session, and a 52-week range of ₹25.79–₹46.34. Check BIOFILCHEM 52-week performance for the annual price range and momentum. Use the Biofil Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Biofil Chemicals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹35 and net income of ₹1, with EBITDA of ₹1, an operating margin of 5.0% and a profit margin of 2.9%.
Biofil Chemicals Share Price Chart
Track the current stock price of Biofil Chemicals with an interactive chart. Analyse BIOFILCHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Biofil Chemicals stock quote in one place.
The quote of ₹29.64 sits between the 52-week low of ₹25.79 and the 52-week high of ₹46.34, and the latest session moved 1.13% from the previous close.
Biofil Chemicals Company Profile - Fundamental Screener
Screen Biofil Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOFILCHEM shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE829A01014.
Company Details
Classification
Identifiers and Leadership
Biofil Chemicals Balance Sheet Screener
Screen BIOFILCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹43, down from ₹51 in 2025.
Latest statistics put total assets at ₹43 and shareholder funds at ₹22, with a leverage ratio of 0.09.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 43 | 51 | 47 | 31 | 19 | 33 | 42 | 24 | 24 | 22 |
| Current Assets | 36 | 43 | 38 | 22 | 9 | 24 | 32 | 14 | 15 | 13 |
| Fixed Assets | 7 | 8 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 22 | 19 | 18 | 17 | 17 | 16 | 15 | 14 | 13 | 13 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves & Surplus | 5 | 3 | 2 | 1 | 1 | 0 | -1 | -3 | -3 | -4 |
Biofil Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Biofil Chemicals income statement and profit fundamentals. Analyze BIOFILCHEM quarterly results. Biofil Chemicals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹35 and net profit was ₹1, equal to earnings per unit of ₹0.30, at an operating margin of 5%.
In that period expenses were ₹34, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹32 and net profit of ₹3.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 35 | 32 | 34 | 41 | 30 | 23 | 37 | 30 | 23 | 13 | 14 | 14 | 6 |
| Expenses | 34 | 28 | 33 | 39 | 29 | 21 | 34 | 28 | 22 | 11 | 11 | 12 | 5 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 1 | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 3 | 1 | 1 |
| Operating Profit % | 5.00% | 2.00% | 3.00% | 2.00% | 4.00% | 6.00% | 4.00% | 6.00% | 4.00% | 8.00% | 19.00% | 7.00% | 13.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| EPS | 0.30 | 1.71 | 0.34 | 0.44 | 0.34 | 0.44 | 0.77 | 0.74 | 0.30 | 0.29 | 1.10 | 0.48 | 0.36 |
Biofil Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen BIOFILCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹1, and net cash flow was an inflow of ₹3.
Over the same period, investing activities provided ₹1 and financing activities provided ₹3.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -1 | -2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Investing Activities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 3 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 |
| Net Cash Flow | 3 | -2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biofil Chemicals Shareholding Pattern Screener
See Biofil Chemicals shareholding pattern with promoter, FII, and DII holdings. Check Biofil Chemicals promoter holding and ownership changes for BIOFILCHEM on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 46.79%, foreign institutions 0.00%, domestic institutions 0.08% and the public 38.40%, spread across 25,356 shareholders.
The shareholder count was 25,356 in 2026-Mar, compared with 24,999 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 46.79% | 46.79% | 46.82% | 46.82% | 46.79% | 46.79% | 46.82% | 46.82% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
| DII Holding | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.40% | 38.63% | 38.31% | 38.18% | 38.23% | 38.27% | 38.03% | 37.27% |
| Other Holding | 14.73% | 14.49% | 14.79% | 14.92% | 14.89% | 14.86% | 15.04% | 15.83% |
| Shareholder Count | 25,356 | 24,999 | 25,914 | 25,685 | 25,196 | 24,825 | 26,581 | 25,480 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Biofil Chemicals. Biofil Chemicals dividend yield can be compared with peers and other stocks in the market.
Biofil Chemicals Stock Index Membership - Nifty & Sensex
See which indices include Biofil Chemicals stock. Check BIOFILCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Biofil Chemicals Market Events Screener - Corporate Actions
Get Biofil Chemicals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Biofil Chemicals stock events that may affect BIOFILCHEM share price, along with derivatives, futures and options activity and sector gainers.
11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.
It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Annual General Meeting | NA | -2.12% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 3.45% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 10.76% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -10.98% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.78% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -3.51% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.89% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 9.64% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -2.62% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -9.36% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 23.96% |
Biofil Chemicals Competitors Screener - Peer Stocks Comparison
Screen BIOFILCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Biofil Chemicals Company Announcements - News & Reports Screener
Screen BIOFILCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 26, 2026.
The next most recent announcements are dated September 26, 2026 and September 26, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-26 | Information Regarding E-Voting For 41St Annual General Meeting | - |
| 2026-08-26 | Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants | - |
| 2026-08-26 | Reg. 34 (1) Annual Report. | - |
| 2026-08-26 | Submission Of Notice Of Convening 41St AGM Of The Company. | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-11 | Un-Audited Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-01 | Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Tuesday 11Th August 2026. | - |
| 2026-07-01 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Audited Financial Result For The Financial Year Ended 31.03.2026 | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 30Th May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹29.64, within a 52-week range of ₹25.79 to ₹46.34. The P/E ratio is 101.03 and the P/B ratio is 2.29, with earnings per unit of ₹1.71. Market capitalisation stands at ₹47.70 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.